End of clinical trials?

I’ve just read about the most recent update from the Parexel / TeGenero clinical trials that went wrong (Elephant men). The four people who were hardest hit appear to have lost a large chunk of their immune system. Translation: they’ll die, pretty quickly,...

Personal development

There’s some useful stuff on this blog “Personal Development for Smart People”, but the tone of it puts my teeth on edge like scratching blackboards.

Multi-dimensional teams

Interesting discussion from Maister on how all of the onion layers of modern working can and should interlink. Is my project / team / office / country / client / boss / industry / specialism the focus of my effort? I can’t do all of them, as there are just too...

Khums

So I’d never heard of khums, an Islamic tax system separate to zakat (which I had heard of). (Lots of good stuff in opendemocracy, by the way.) The article argues that cutting off funding through Lebanon will not cut off funding for Hizbollah, as they could be...

Long tail shrinking

Looks like the game’s up for the long tail. 80/20 is becoming 70/30, maybe. But Amazon makes 75% of sales from 100,000 items (that’s 2.7% of its stock). So looks like my earlier thoughts were on track. The question now is whether the “mid”...